Treatment with 40 mg/kg CPUY201112 remarkably induced the expression of Hsp70 and decreased the expression of Akt, suggesting that tumor regression was caused by CPUY201112 through targeting Hsp90. This evidence concerns the gene AKT1 and neoplasm.